MARVIN ZELMAN: Open Payments
NPI 1578775706 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 9 payments from 4 companies in 2025. Trend: 2023 $439 · 2024 $558 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $368 |
| Alkermes, Inc. | 3 | $366 |
| Axsome Therapeutics, Inc. | 2 | $194 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
Products named: REXULTI, LYBALVI, Auvelity, ARISTADA, ABILIFY MAINTENA, FANAPT.
Industry payments across CT — which companies pay providers there.
